New disposable scope cover may lower infection risk in gut procedures
NCT ID NCT05429203
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested two types of endoscopes used in ERCP, a procedure to treat bile duct and pancreas problems. One scope had a single-use plastic cover on its tip, while the other was a standard reusable scope. Researchers compared how well each worked and how often complications like infection or bleeding occurred. The trial included 319 adults and aimed to see if the disposable cover could make the procedure safer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Duodenoscope with single-use distal cover
- What this could lead to
- If successful, this could show that a single-use cover reduces infection risk during ERCP while maintaining procedure success.
- What could go wrong
- This is a completed device comparison, not a new treatment. The main benefit is infection control, not curing disease. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford hospital
Palo Alto, California, 943305, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new imaging trick spot pancreatic cancer without a biopsy?
- Can High-Dose vitamin c boost chemo against pancreatic cancer?
- AI assistant could spot hidden liver and pancreas cancers earlier
- Could a simple blood test catch pancreatic cancer before It's too late?
- Tailored nutrition after pancreatic surgery could speed recovery
- Engineered immune cells take aim at Mesothelin-Positive tumors